Wanxing Chai-Ho

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Tyrosine Kinase

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Naval G Daver, Paresh Vyas, Suman Kambhampati, Monzr M Al Malki, Richard A Larson, Adam S Asch, Gabriel Mannis, Wanxing Chai-Ho, Tiffany N Tanaka, Terrence J Bradley, Deepa Jeyakumar, Eunice S Wang, Kendra Sweet, Hagop M Kantarjian, Guillermo Garcia Manero, Rami S Komrokji, Guan Xing, Giridharan Ramsingh, Camille Renard, Joshua F Zeidner, David A Sallman
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Antonia Angeli Gazola, Deborah J Wong, Robert Chin, John Nikitas, Christine J Kim, Steven D Hart, Maie St John, Wanxing Chai-Ho
Excellent Response to Fam-Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma With CNS Metastasis: A Case Report. JCO precision oncology 6 (2022)